Press release
Oligonucleotide Synthesis Market Forecast 2025-2030: Growth Trends, Key Drivers & Future Outlook
Europe ranks second in terms of growth. The key revenue contributing countries include Germany, UK, and France.
Why Oligonucleotide Synthesis Matters in 2025
The global [https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html] is entering a high-growth phase, fueled by advancements in genomics, therapeutics, and diagnostics. Valued at US$8.9 billion in 2024, the market reached US$10.5 billion in 2025 and is expected to skyrocket to US$24.7 billion by 2030, reflecting an impressive CAGR of 18.6%.
As precision medicine, genetic testing, and RNA-based therapeutics reshape modern healthcare, the demand for high-quality synthesized oligonucleotides is accelerating worldwide. This surge underscores their pivotal role in drug discovery, disease diagnosis, and personalized treatment pathways.
[https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350]
Market Growth Insights & Trends
The oligonucleotide synthesis market is witnessing rapid expansion, supported by:
* Strong CAGR (2025-2030): 18.6%
* Forecasted valuation by 2030: US$24.7 billion
* Key industries adopting oligonucleotides: pharmaceuticals, biotechnology, diagnostics, and academic research
Trending applications include:
* Gene editing technologies (CRISPR-Cas9)
* RNA-based drugs (mRNA vaccines, antisense therapies, siRNA therapies)
* Companion diagnostics and biomarker discovery
* Synthetic biology & molecular diagnostics
Key Drivers of Market Growth
* Rising Demand for RNA Therapeutics
* mRNA vaccines and RNA interference (RNAi) therapies are expanding the role of oligonucleotides in healthcare.
* Advancements in Genomic Research
* Growing adoption of next-generation sequencing (NGS) and synthetic biology is creating a higher need for custom oligonucleotide synthesis.
* Personalized & Precision Medicine
* Tailored therapeutics and diagnostics depend on accurate oligonucleotide sequences, boosting demand.
* Biotech & Pharma Industry Expansion
* Increased investments in biotech R&D and drug pipelines are fueling large-scale oligonucleotide production.
Challenges & Opportunities
Challenges:
* High cost of synthesis technologies
* Complex regulatory landscape for nucleic acid-based drugs
* Quality control and scalability issues in manufacturing
Opportunities:
* Growth in custom oligonucleotide services for research labs and biotech startups
* Expansion of therapeutic oligonucleotides in oncology and rare diseases
* Integration of AI & automation in oligonucleotide synthesis to reduce costs and enhance efficiency
[https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350]
Competitive Landscape: Key Players
The oligonucleotide synthesis market is highly competitive, with major companies investing heavily in R&D and advanced manufacturing platforms. Leading players include:
* Agilent Technologies
* Thermo Fisher Scientific
* Integrated DNA Technologies (IDT)
* Merck KGaA
* Eurofins Genomics
* Twist Bioscience
* Bio-Synthesis Inc.
Future Outlook: Oligonucleotide Synthesis Market by 2030
Looking ahead, the future of the oligonucleotide synthesis industry will be shaped by:
* Wider adoption of RNA-based drugs beyond COVID-19 vaccines
* Innovations in synthetic biology enabling advanced therapeutic platforms
* Increased clinical validation of antisense and siRNA therapies
* Partnerships between pharma, biotech, and contract manufacturers to scale production
By 2030, oligonucleotides are expected to play a mainstream role in personalized medicine, reshaping drug pipelines and diagnostic strategies globally.
Conclusion & Call-to-Action
The oligonucleotide synthesis market is on track to nearly triple in value by 2030, making it one of the most dynamic segments in biotechnology. With applications spanning therapeutics, diagnostics, and genomics, this sector represents a prime opportunity for investors, biotech firms, and healthcare innovators.
Businesses that invest in advanced oligonucleotide synthesis today will lead the future of precision medicine tomorrow.
For more information, [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=200829350]
FAQs
1. What is driving growth in the oligonucleotide synthesis market? The market is driven by the rising use of oligonucleotides in RNA-based drugs, diagnostics, and personalized medicine.
2. How big will the oligonucleotide synthesis market be by 2030? It is projected to reach US$24.7 billion by 2030, growing at a CAGR of 18.6%.
3. Which companies are leading in oligonucleotide synthesis? Key players include Thermo Fisher Scientific, Agilent Technologies, Integrated DNA Technologies, Merck KGaA, and Twist Bioscience.
4. What are the challenges in oligonucleotide synthesis? Challenges include high production costs, regulatory complexity, and scalability issues.
5. How are oligonucleotides used in therapeutics? They are applied in mRNA vaccines, antisense therapies, siRNA treatments, and precision medicine
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=oligonucleotide-synthesis-market-forecast-20252030-growth-trends-key-drivers-future-outlook]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oligonucleotide Synthesis Market Forecast 2025-2030: Growth Trends, Key Drivers & Future Outlook here
News-ID: 4296235 • Views: …
More Releases from ABNewswire
The End of the "Latin Courier": aiomics Reinvents the Patient Letter as a Person …
Moving beyond administrative automation, aiomics is now being used to transform the discharge letter-traditionally a jargon-heavy handover between doctors-into a patient-centric recovery plan. The new application tailors medical data to patients' education, life goals, and constraints, operationalizing the vision of Shared Decision Making advocated by Dr. Sven Jungmann and colleagues in recent white paper.
BERLIN - For generations, the medical discharge letter has treated the patient as little more than a…
A Perfect Finish Painting Broadens Painter Offerings Across Littleton, CO, Servi …
A Perfect Finish Painting continues to serve homeowners and property managers across Littleton and Sedalia with dependable workmanship and consistent project support. With a focus on reliability, local understanding, and clear communication, A Perfect Finish Painting remains dedicated to meeting the needs of the communities it serves through professional, well-managed painting solutions.
Introduction: Expanding Exterior Painting in Littleton, CO
A Perfect Finish Painting continues to reinforce its role as a dependable local…
Burghley Capital: JD Property Reapplies for HK IPO
JD.com's property management arm presses on with a renewed Hong Kong flotation filing, pointing to revenue growth, narrowing losses and global logistics expansion as investors weigh the exchange pipeline and China's restructuring drive.
Image: https://www.abnewswire.com/upload/2026/02/546bff015745ceefeaf226f6d1693e6b.jpg
In the final week of January, Burghley Capital is tracking Jingdong Property's refreshed Hong Kong IPO application as a live gauge of how global investors price China-linked infrastructure services, where fee income and execution discipline increasingly carry…
Healthcare Teams Adopt Aiomics to Break "Groupthink" and Improve Interdisciplina …
Forward-thinking providers in sports medicine, oncology, and functional medicine are utilizing aiomics' workflow software to implement "Brain Writing." By structuring how teams prepare for case reviews, the platform ensures diverse expert opinions are captured and organized before the discussion begins.
BERLIN - In complex healthcare environments, the quality of a decision often depends on the quality of the conversation that precedes it. Aiomics, the Berlin-based healthcare software company, is seeing its…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
